🇩🇪 Germany · EU Public Tender
Abschluss einer Vereinbarung zu Polivy(R) (Wirkstoff Polatuzumab vedotin, ATC: L01XC) zwischen der Roche Pharma GmbH und der IKK classic rückwirkend zum 21.1.2020
🏛️ IKK classic · 📍 Dresden
1 €
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Awarded to | Roche Pharma GmbH |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.